Beilu Pharma plans to raise no more than 300 million yuan through a simplified procedure for a private placement
Beilu Pharma plans to issue shares to specific targets through a simplified procedure, raising no more than 300 million yuan. This issuance will be directed at no more than 35 specific targets, with the issuance price not lower than 80% of the average price of the 20 trading days prior to the pricing benchmark date. The raised funds will be used for the production workshop and intelligent comprehensive warehouse project of Luzhibao Pharmaceutical, technological transformation projects, and to supplement working capital
According to the Zhitong Finance APP, Beilu Pharma (300016.SZ) disclosed a plan to issue stocks to specific targets through a simplified procedure for the year 2025. The company plans to issue stocks to no more than 35 individuals (inclusive), with the issuance price not lower than 80% of the average trading price of the company's stocks over the twenty trading days prior to the pricing benchmark date. The number of shares issued will be determined by dividing the total amount of funds raised by the issuance price, and will not exceed 30% of the company's total share capital before this issuance. The total amount of funds raised through this simplified procedure for issuing stocks to specific targets will not exceed 300 million yuan (inclusive), and the net amount of funds raised after deducting related issuance expenses will be fully invested in the production workshop and intelligent comprehensive warehouse project of Luzhibao Pharmaceutical, the technical transformation project for the new production line of 100 tons of Iodinated Methylpyrrolidone and 50 tons of Iodinated Butanol raw materials, and to supplement working capital
